ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,530Medicare Part D Prescriptions Filled, Including Refills

Rank: 218 out of 1692

$211K Total Retail Price of All Prescriptions

Rank: 835 out of 1692

243 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 243 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 243 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,411 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$22 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 402 335 1 1
OYSTER SHELL CALCIUM W-VIT D 374 374 10 2 270
LISINOPRIL 354 307 3 2
AMLODIPINE BESYLATE 322 280 4 3
MAPAP 260 234 5 302
METFORMIN HCL 236 196 6 8
CITALOPRAM HBR 229 185 7 21
HYDROCHLOROTHIAZIDE 217 194 8 9
ALENDRONATE SODIUM 217 199 8 36
ASPIRIN 215 199 10 200
MELATONIN 211 211 10 11 289
FUROSEMIDE 209 203 12 7
SENNA PLUS 200 199 13 256
METOPROLOL TARTRATE 194 133 14 10
NAMENDA 187 187 15 50
OMEPRAZOLE 185 139 16 5
DOK 176 167 17 296
NEXIUM 146 134 18 25
GABAPENTIN 142 133 19 13
LOSARTAN POTASSIUM 129 121 20 17
LEVOTHYROXINE SODIUM 127 115 21 4
DONEPEZIL HCL 119 119 22 29
THERA 118 110 10 23 343
VITAMIN D 116 114 24 201
QUETIAPINE FUMARATE 114 114 25 62
WARFARIN SODIUM 109 99 26 14
SERTRALINE HCL 108 105 27 22
TRAMADOL HCL 107 87 28 16
KLOR-CON M20 87 87 29 48
DILTIAZEM 24HR CD 87 87 29 96
MIRTAZAPINE 86 86 31 53
BUSPIRONE HCL 84 84 32 122
ASPIRIN EC 81 81 33 237
TAMSULOSIN HCL 81 65 33 31
CALCIUM 76 64 35 408
ENALAPRIL MALEATE 71 71 36 71
METOPROLOL SUCCINATE 69 66 37 18
HYDROCODONE-ACETAMINOPHEN 67 47 S3 38 6
FINASTERIDE 63 63 39 99
MAPAP ARTHRITIS PAIN 59 59 40 430
FLUTICASONE PROPIONATE 59 49 40 27
DIVALPROEX SODIUM 57 57 42 97
JANUVIA 54 45 43 72
NIFEDIPINE ER 54 54 43 114
GLIPIZIDE ER 53 52 45 87
LOSARTAN-HYDROCHLOROTHIAZIDE 53 53 45 38
DIOVAN 52 52 47 42
OXYBUTYNIN CHLORIDE 52 52 47 162
VESICARE 52 52 47 231
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.